0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD…
Recall D-0374-2019, part of FDA recall event 81895. See PharMEDium Services's company page.
PharMEDium Services, LLC. started this Class II drug recall on Jan 2, 2019 (voluntary: firm initiated); FDA lists it as terminated, terminated May 7, 2020.
- Classification: Class II
- Started: Jan 2, 2019
- Status: Terminated
Why It Was Recalled
Class IISubpotent
Record
- Product
- 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) 5 mL in 5 mL BD Syringe, 10 per carton Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478.
- Quantity
- 7,711 syringes
- Lots and codes
- Service Code 2K2466 and 2K2470 183320004S, 183330008S, 183340002S, 183340003S, 183300004S, 183310007S, 183370041S, 183310043S, 183370042S, 183320003S, 183380007S, 183250013S, 183250014S, 183320005S, 183330009S, 183370007S, 183390044S, 183400006S, 183410003S.
- Distribution
- Product was distributed throughout the United States.
- Recalling firm
- PharMEDium Services, LLC., Cleveland, MS, United States
- How the firm notified
- Letter
- FDA classified
- Jan 14, 2019
PharMEDium Services, LLC.'s Other Recalls
Newest first, one product per recall event; search them all- Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only ,…D-0080-2018 · Class II · Oct 13, 2017 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports